Full-time researcher, Shenzhen Samii Medical Center

Postdoctor, Southeast University

Doctor of Biology, Uni-Freiburg

Main Research Field

(1) Pathogenesis of clostridium difficile infection

(2)Screening and identification of new antimicrobial metabolites.

Representative Research Achievements

1. Biological functions of C-terminal domain of Clostridium difficile B.

2.Identification of the important role of SREBP-2 pathway in C. difficile Toxin B binding and presenting to host cells.

Representative SCI Papers Published

1.Yuan B, Liu HQ, Yang ZR, Chen YX, Liu ZY, Zhang K, Wang C, Li WX, An YW, Wang JC^#, Song S^#, Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation. Sci Rep. 2020;10(1):11887. (IF 3.998)

2. Papatheodorou P^$, Song S^$et al., 2019, Cytotoxicity of Clostridium difficile toxin A and B requires an active and functional SREBP-2 pathway. FASEB J.33(4):4883-4892. (IF 4.966)

3. Schorch B^$, Song S^$et al., 2014, LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of clostridial glycosylating toxins. Proc Natl Acad Sci U S A 111(17), pp.6431–6436. (IF 9.708)